Advancing smartphone based adaptive automated insulin delivery (AID)

mylife Diabetescare Stories

Ypsomed has entered into a cooperation with CamDiab Ltd. to further simplify your diabetes therapy. CamDiab Ltd. is the developer of CamAPS FX, an easy to set up and use app which works seamlessly with your Dexcom G6 sensor and your mylife YpsoPump insulin pump. Thanks to the upcoming integration of automated insulin delivery (AID) into the mylife YpsoPump system, you will be afforded more time away from your diabetes, and more spontaneity in your daily life. This easy-to-use loop solution will be launched for the mylife YpsoPump system, starting in selected countries and followed by other Ypsomed territories in the course of the year.

Read more...

100 years of insulin

The success story of a life-saving hormone

mylife Diabetescare Stories

In July 1921, Canadian researchers Frederick Banting and his assistant Charles Best achieved a revolutionary breakthrough: they succeeded in isolating insulin from dogs’ pancreas for the first time and were also able to demonstrate its blood glucose-lowering effect - thus laying the most important foundation stone for the effective treatment of diabetes mellitus. At last there was justified hope of saving the lives of children with diabetes, who until then had only survived an average of one to two years after diagnosis without any option of therapy.

Read more...

Clickfine pen needles now available at Save-on-Foods pharmacies

mylife Diabetescare Stories

Save-on-Foods pharmacies across western Canada are now carrying the Clickfine 6-bevel needle tips.

Read more...

Continuous therapy management via smartphone

mylife Diabetescare Stories

Burgdorf – Ypsomed has expanded the range of features of the mylife YpsoPump insulin pump system.

Read more...